Holly Siegfried

PHD Doctor of Philosophy,  The Johns Hopkins Hospital 

Location: Africa

Consulting Services

Sales and Marketing Career Advice and Mentoring Biostatistics Grant Submission Case Consulting

Areas Of Interest

Republic of Latvia Meningococcus, Serogroup B Rhizobium radiobacter Mean Corpuscular Volume Methylene Diphosphonate, Tc-99m Dispersion, Optical Rotatory Sodium-driven chloride bicarbonate exchanger Radiographies, Panoramic Mouse, Founder, Transgenic Dermatofibrosarcoma Protuberans, Myxoid Bromide, Pipecurium Interferon, alpha Mice, Quaking Heptoses RNA Recognition Motif M-Phase Inducer Phosphatase 3 Major Core Protein Trichonympha BRL14151 Linguali, Gyrus Ribonucleoproteins, Small, U4-U6 Paracrine Peptide Factors Ocular Tension Bunyaviridae Osteogenesis Imperfecta with Blue Sclerae Semen Donor Apo A-2 Inhospital Mortalities Non-Transmembrane Protein Tyrosine Phosphatases Toxoplasma Infection, Congenital Diode Lasers Partial Third-Nerve Palsy

Professional Narrative

Dr. Holly Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2013
Senior Director, Amgen 2004

Education

Bachelor of science in nursing, Yale School of Medicine 1996
Director Medicine, Yale School of Medicine 1987

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :